April 22, 2025CorporateTerumo unveils “Terumo Group Statement on Nature,” a guideline for its actions on conservation and restoration of natural environments
April 16, 2025CorporateTerumo Blood and Cell Technologies Names Patrick Daly as Chief Business OfficerDaly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help Terumo BCT unite business areas and fuel enterprise growth
April 16, 2025CorporateTerumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US– Innovative AI software supports hospital adoption of advanced tools to improve cath lab workflow and patient comfort –
April 01, 2025 Terumo announces changes to the names of some businesses within the Cardiac and Vascular Company (PDF 117.21 KB) Disclosure segments of Blood and Cell Technologies Company to also be revised February 14, 2025 Audio webcast and Q&A regarding Financial Results for the Third Quarter of FYE 3/2025 February 13, 2025 Presentation regarding Financial Results for the Third Quarter of FYE 3/2025 December 03, 2024 Notice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) November 08, 2024 Audio webcast and Q&A regarding Financial Results for the Second Quarter of FYE 3/2025 November 07, 2024 Presentation regarding Financial Results for the Second Quarter of FYE 3/2025 November 07, 2024 Notice Concerning Revisions to Full-Year Consolidated Financial Guidance for Fiscal Year Ending March 31, 2025 (FY2024) (PDF 85.27 KB) November 05, 2024 Notice Concerning Status of Acquisition of Own Shares (PDF 82.32 KB) October 02, 2024 Notice Concerning Status of Acquisition of Own Shares (PDF 82.32 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) September 10, 2024 Notice Concerning Confirmation of Acquisition Period of Own Shares (PDF 131.51 KB) August 29, 2024 Notice Concerning Secondary Offering of Shares in the International Markets (PDF 316.27 KB) August 29, 2024 Notice Concerning Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 134.55 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan, and cancellation of treasury stock pursuant to the Article 178 of the Companies Act of Japan) August 14, 2024 Audio webcast regarding Financial Results for the First Quarter of FYE 3/2025 August 08, 2024 Presentation regarding Financial Results for the First Quarter of FYE 3/2025 August 02, 2024 Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 114.6 KB) August 02, 2024 Notice Concerning Completion of Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 104.8 KB) July 11, 2024 Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 142.31 KB) July 11, 2024 Notice Concerning the Issuance of Stock Options (Share Warrants) (PDF 114.67 KB) May 15, 2024 Audio webcast regarding Financial Results for FYE 3/2024 May 14, 2024 Presentation regarding Financial Results for FYE 3/2024 March 11, 2024 Notice Concerning the Status and Completion of the Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 130.35 KB) March 11, 2024 Notice Concerning Partial Amendment to “Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation” (PDF 115.61 KB) March 04, 2024 Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.47 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) February 09, 2024 Q&A regarding Financial Results for the Third Quarter of FYE 3/2024 February 08, 2024 Audio webcast regarding Financial Results for the Third Quarter of FYE 3/2024 February 07, 2024 Presentation regarding Financial Results for the Third Quarter of FYE 3/2024 February 07, 2024 Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation (PDF 123.59 KB) February 07, 2024 Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2024 (FY2023) (PDF 82.66 KB) January 09, 2024 Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.48 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) December 14, 2023 Notice Concerning the Change of Executive Officers as of April 1, 2024 (PDF 0 bytes) December 04, 2023 Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.21 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) November 16, 2023 Q&A regarding Financial Results for the First Half of FYE 3/2024 November 15, 2023 Audio webcast regarding Financial Results for the First Half of FYE 3/2024 November 14, 2023 Presentation regarding Financial Results for the First Half of FYE 3/2024 November 02, 2023 Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.38 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) September 04, 2023 Notice Concerning the Status of the Acquisition of Own Shares (PDF 108.68 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) August 14, 2023 Q&A regarding Financial Results for the First Quarter of FYE 3/2024 August 10, 2023 Audio webcast regarding Financial Results for the First Quarter of FYE 3/2024 August 09, 2023 Notice Concerning Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 107.04 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan, and cancellation of treasury stock pursuant to the Article 178 of the Act) August 09, 2023 Presentation regarding Financial Results for the First Quarter of FYE 3/2024 August 02, 2023 Notice of Completion of Disposal of Treasury Shares as Restricted Stock Remuneration Plan (PDF 101.3 KB) August 02, 2023 Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 66.24 KB) July 13, 2023 Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 132.32 KB) July 13, 2023 Notice Concerning the Issuance of Stock Options (Share Warrants) (PDF 111.61 KB) May 17, 2023 Q&A regarding Financial Results for FYE 3/2023 May 16, 2023 Audio webcast regarding Financial Results for FYE 3/2023 May 15, 2023 Presentation regarding Financial Results for FYE 3/2023 February 13, 2023 Q&A regarding Financial Results for the Third Quarter of FYE 3/2023 February 13, 2023 Audio webcast regarding Financial Results for the Third Quarter of FYE 3/2023 February 09, 2023 Presentation regarding Financial Results for the Third Quarter of FYE 3/2023 Pagination Previous page ‹ Current page1 Page2 Next page ›
April 01, 2025 Terumo announces changes to the names of some businesses within the Cardiac and Vascular Company (PDF 117.21 KB) Disclosure segments of Blood and Cell Technologies Company to also be revised
February 14, 2025 Audio webcast and Q&A regarding Financial Results for the Third Quarter of FYE 3/2025
December 03, 2024 Notice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
November 08, 2024 Audio webcast and Q&A regarding Financial Results for the Second Quarter of FYE 3/2025
November 07, 2024 Notice Concerning Revisions to Full-Year Consolidated Financial Guidance for Fiscal Year Ending March 31, 2025 (FY2024) (PDF 85.27 KB)
October 02, 2024 Notice Concerning Status of Acquisition of Own Shares (PDF 82.32 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
September 10, 2024 Notice Concerning Confirmation of Acquisition Period of Own Shares (PDF 131.51 KB)
August 29, 2024 Notice Concerning Secondary Offering of Shares in the International Markets (PDF 316.27 KB)
August 29, 2024 Notice Concerning Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 134.55 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan, and cancellation of treasury stock pursuant to the Article 178 of the Companies Act of Japan)
August 02, 2024 Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 114.6 KB)
August 02, 2024 Notice Concerning Completion of Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 104.8 KB)
July 11, 2024 Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 142.31 KB)
March 11, 2024 Notice Concerning the Status and Completion of the Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 130.35 KB)
March 11, 2024 Notice Concerning Partial Amendment to “Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation” (PDF 115.61 KB)
March 04, 2024 Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.47 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
February 07, 2024 Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation (PDF 123.59 KB)
February 07, 2024 Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2024 (FY2023) (PDF 82.66 KB)
January 09, 2024 Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.48 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
December 14, 2023 Notice Concerning the Change of Executive Officers as of April 1, 2024 (PDF 0 bytes)
December 04, 2023 Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.21 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
November 02, 2023 Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.38 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
September 04, 2023 Notice Concerning the Status of the Acquisition of Own Shares (PDF 108.68 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
August 09, 2023 Notice Concerning Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 107.04 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan, and cancellation of treasury stock pursuant to the Article 178 of the Act)
August 02, 2023 Notice of Completion of Disposal of Treasury Shares as Restricted Stock Remuneration Plan (PDF 101.3 KB)
August 02, 2023 Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 66.24 KB)
July 13, 2023 Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 132.32 KB)
Top
Top